135 related articles for article (PubMed ID: 37452691)
1. Ginsenoside Rh4 inhibits the malignant progression of multiple myeloma and induces ferroptosis by regulating SIRT2.
Ying Q; Lou J; Zheng D
Clin Exp Pharmacol Physiol; 2023 Sep; 50(9):757-765. PubMed ID: 37452691
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
Ding T; Hao J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh4 Inhibits Colorectal Cancer Cell Proliferation by Inducing Ferroptosis via Autophagy Activation.
Wu Y; Pi D; Chen Y; Zuo Q; Zhou S; Ouyang M
Evid Based Complement Alternat Med; 2022; 2022():6177553. PubMed ID: 35677385
[TBL] [Abstract][Full Text] [Related]
4. The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo.
Duan Z; Wei B; Deng J; Mi Y; Dong Y; Zhu C; Fu R; Qu L; Fan D
Biochem Biophys Res Commun; 2018 May; 499(3):482-487. PubMed ID: 29596831
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh4 Facilitates the Sensitivity of Renal Cell Carcinoma to Ferroptosis via the NRF2 Pathway.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Mar; 77(2):119-128. PubMed ID: 38583003
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis.
Dong F; Qu L; Duan Z; He Y; Ma X; Fan D
Bioorg Chem; 2023 Jun; 135():106537. PubMed ID: 37043883
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells.
Wu Q; Deng J; Fan D; Duan Z; Zhu C; Fu R; Wang S
Biochem Pharmacol; 2018 Feb; 148():64-74. PubMed ID: 29225132
[TBL] [Abstract][Full Text] [Related]
8. Neratinib inhibits proliferation and promotes apoptosis of acute myeloid leukemia cells by activating autophagy-dependent ferroptosis.
Ma H; Liu Y; Miao Z; Cheng S; Zhu Y; Wu Y; Fan X; Yang J; Li X; Guo L
Drug Dev Res; 2022 Nov; 83(7):1641-1653. PubMed ID: 36031759
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh4 delays skeletal muscle aging through SIRT1 pathway.
Zhu A; Duan Z; Chen Y; Zhu C; Fan D
Phytomedicine; 2023 Sep; 118():154906. PubMed ID: 37354698
[TBL] [Abstract][Full Text] [Related]
10. Amentoflavone promotes ferroptosis by regulating reactive oxygen species (ROS) /5'AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) to inhibit the malignant progression of endometrial carcinoma cells.
Sun Q; Zhen P; Li D; Liu X; Ding X; Liu H
Bioengineered; 2022 May; 13(5):13269-13279. PubMed ID: 35635082
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 2 in Endometrial Cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway.
Guo Y; Zhao N; Zhou J; Dong J; Wang X
Technol Cancer Res Treat; 2020; 19():1533033820980781. PubMed ID: 33327875
[TBL] [Abstract][Full Text] [Related]
12. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.
Jin L; Tong L
Immun Inflamm Dis; 2021 Sep; 9(3):827-839. PubMed ID: 33955706
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer.
Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D
Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Quercetin on Proliferation and Apoptosis of Multiple Myeloma Cells and Its Related Mechanism].
Xu YW; Zou LF; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1234-1239. PubMed ID: 32798404
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling.
Zhang Y; Ma P; Duan Z; Liu Y; Mi Y; Fan D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216134
[TBL] [Abstract][Full Text] [Related]
16. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.
He W; Fu Y; Zheng Y; Wang X; Liu B; Zeng J
BMC Cancer; 2021 Feb; 21(1):125. PubMed ID: 33549034
[TBL] [Abstract][Full Text] [Related]
17. Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4.
To KI; Zhu ZX; Wang YN; Li GA; Sun YM; Li Y; Jin YH
Front Pharmacol; 2022; 13():953871. PubMed ID: 36120306
[TBL] [Abstract][Full Text] [Related]
18. Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Ni Y; Yang Z; Agbana YL; Bai H; Wang L; Yang L; Yi Z; Cheng J; Zhang Q; Kuang Y; Zhu Y
Cancer Sci; 2021 Oct; 112(10):4075-4086. PubMed ID: 34310804
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway.
Chen J; Duan Z; Liu Y; Fu R; Zhu C
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893895
[TBL] [Abstract][Full Text] [Related]
20. Induction of Apoptosis, Autophagy and Ferroptosis by
N Adham A; F Hegazy ME; Naqishbandi AM; Efferth T
Molecules; 2020 Oct; 25(21):. PubMed ID: 33138135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
